Opportunity Information: Apply for RFA AG 22 013
The High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional) opportunity (RFA-AG-22-013) is a National Institutes of Health grant program designed to build and strengthen behavioral and social science research networks focused on aging across the life course. The core purpose is not just to fund standalone studies, but to create research and research infrastructure that helps the field tackle big, shared problems in population aging research. In line with recommendations from the 2019 BSR NACA Review, the FOA emphasizes efforts that can expand the scientific workforce in aging research, make it easier to do high-quality, comparable research across studies, and support the kinds of large-scale data resources that allow researchers to answer long-term questions about aging, health, and well-being.
A central theme of the program is life course research on aging, meaning research that considers how experiences and exposures earlier in life shape outcomes in midlife and older age. The FOA also explicitly aims to attract new researchers into aging, which typically points to network activities such as training, mentorship pipelines, shared methods resources, pilot opportunities, and collaborative structures that lower the barrier to entry for investigators who are new to aging research. Another major priority is to infuse a strong focus on health disparities into aging research, encouraging applicants to build networks and infrastructure that can better study and ultimately reduce inequities by race, ethnicity, socioeconomic status, geography, disability status, and other factors that influence how people age and what resources they can access.
The announcement highlights ongoing needs around harmonization and biomarker collection in large population panel studies. Harmonization generally refers to aligning measures, constructs, and protocols across different studies so results can be compared or combined, which is especially important when multiple longitudinal panel datasets exist but use different instruments, coding, or collection schedules. Biomarker collection signals an interest in strengthening the integration of biological measures with behavioral and social data, so that population studies can connect social conditions and lived experience with physiological processes and health outcomes. In practice, projects under this FOA would be expected to support shared standards, common data elements, coordinated protocols, and related infrastructure that makes large-scale aging research more interoperable and scientifically powerful.
This is an R24 mechanism, which is commonly used for resource-related and infrastructure-building projects rather than traditional hypothesis-driven R01-style research alone. The FOA is labeled "Clinical Trial Optional," meaning applicants may propose a clinical trial if it fits their aims, but they are not required to do so. The funding instrument is a grant, the activity category is health, and the CFDA number listed is 93.866. The award ceiling shown in the source information is $250,000, and the original closing date listed is 2021-06-23, with a creation date of 2021-03-18.
Eligibility is broad and includes many types of U.S.-based organizations and government entities. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments that are federally recognized; public housing authorities and Indian housing authorities; tribal organizations other than federally recognized tribal governments; nonprofits with and without 501(c)(3) status (excluding higher education institutions in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other eligible entities. The FOA also explicitly calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, Indian/Native American tribal governments that are not federally recognized, and U.S. territories or possessions.
At the same time, the FOA places clear limits on foreign participation. Non-domestic (non-U.S.) entities and non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed, which typically means a U.S. applicant organization can include certain well-justified foreign activities or collaborations within the rules NIH sets for foreign components, even though the applicant institution itself must be domestic.
Overall, the opportunity is best understood as NIH support for building the connective tissue of aging research: networks, shared tools, harmonized measurement approaches, and biomarker-related infrastructure that make large population aging studies more comparable, more inclusive, and more capable of addressing health disparities and life course questions at scale.Apply for RFA AG 22 013
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2021-03-18.
- Applicants must submit their applications by 2021-06-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional) opportunity?
It is a National Institutes of Health (NIH) funding opportunity (RFA-AG-22-013) that supports building and strengthening behavioral and social science research networks focused on aging across the life course. The emphasis is on developing research networks and shared infrastructure that help the broader field address major, shared challenges in population aging research.
What is the main purpose of this FOA?
The main purpose is to support research networks and research infrastructure rather than funding only standalone studies. Projects are expected to create "connective tissue" for the field, such as shared tools, coordinated methods, harmonized measures, and related resources that enable more comparable and scalable aging research.
What does "life course research on aging" mean in this program?
Life course research on aging refers to research that examines how experiences and exposures earlier in life shape outcomes in midlife and older age. The FOA prioritizes network efforts that enable this kind of long-term, population-oriented research.
How does this opportunity aim to expand the aging research workforce?
The FOA highlights goals aligned with expanding the scientific workforce in aging research. This typically points to network-based activities that lower barriers to entry for researchers new to aging, such as training and mentorship pipelines, shared methods resources, pilot opportunities, and collaborative structures.
Is a focus on health disparities required or encouraged?
A strong focus on health disparities is a major priority in the FOA. Applicants are encouraged to build networks and infrastructure that can better study and ultimately reduce inequities linked to factors such as race, ethnicity, socioeconomic status, geography, disability status, and other conditions shaping how people age and what resources they can access.
What types of research infrastructure does the FOA emphasize?
The announcement highlights needs around harmonization and biomarker collection in large population panel studies. In practice, that points to infrastructure such as shared standards, common data elements, coordinated protocols, and related tools that make large-scale aging research more interoperable and scientifically powerful.
What does "harmonization" mean in this context?
Harmonization refers to aligning measures, constructs, and protocols across different studies so results can be compared or combined. This is especially important when multiple longitudinal panel datasets exist but use different instruments, coding, or data collection schedules.
Why does the FOA mention biomarker collection?
The mention of biomarker collection signals an interest in strengthening integration of biological measures with behavioral and social data. The goal is to enable population studies to connect social conditions and lived experiences with physiological processes and health outcomes.
What is an R24 mechanism, and why does it matter here?
An R24 is commonly used for resource-related and infrastructure-building projects rather than traditional hypothesis-driven research projects alone. For this FOA, that means the focus is on building networks, shared tools, and research infrastructure that benefit the broader aging research community.
What does "Clinical Trial Optional" mean?
"Clinical Trial Optional" means applicants may propose a clinical trial if it fits the project aims, but a clinical trial is not required.
What is the funding instrument and activity category?
The funding instrument is a grant, and the activity category is health.
What is the CFDA number for this opportunity?
The CFDA number listed for this opportunity is 93.866.
What is the award ceiling listed for this opportunity?
The award ceiling shown in the source information is $250,000.
What are the key dates provided for this opportunity?
The creation date listed is 2021-03-18, and the original closing date listed is 2021-06-23.
Who is eligible to apply?
Eligibility is broad and includes many U.S.-based organizations and government entities. Examples listed include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; tribal organizations other than federally recognized tribal governments; nonprofits with and without 501(c)(3) status (excluding higher education institutions in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other eligible entities.
Are minority-serving institutions and community-based organizations included in eligibility?
Yes. The FOA explicitly calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, TCCUs, faith-based or community-based organizations, regional organizations, eligible federal agencies, Indian/Native American tribal governments that are not federally recognized, and U.S. territories or possessions.
Are non-U.S. (foreign) organizations eligible to apply?
No. Non-domestic (non-U.S.) entities and non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply under this FOA.
Are foreign collaborations allowed at all?
Yes, foreign components (as defined in the NIH Grants Policy Statement) are allowed. This generally means a U.S. applicant organization may include certain well-justified foreign activities or collaborations within NIH rules, even though the applicant institution itself must be domestic.
What kinds of projects are a good fit for this program?
Projects that build and strengthen aging research networks and shared infrastructure are a good fit, especially those that support life course research, expand the workforce in aging research, improve comparability across studies through harmonization, strengthen biomarker-related infrastructure, and embed a focus on health disparities in population aging research.
Is this opportunity intended to fund a single standalone research study?
The core purpose is not simply to fund standalone studies. The emphasis is on creating research networks and infrastructure that help the broader field address big, shared problems in population aging research.
What is the overall goal of the program in plain terms?
The overall goal is to support NIH-funded efforts that make aging research more connected, more comparable across studies, more inclusive, and better equipped to answer long-term questions about aging, health, and well-being at scale.
Browse more opportunities from the same category: Health
Next opportunity: NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
Previous opportunity: Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 22 013
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 22 013) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research on Bat Immunology (R21 Clinical Trial Not Allowed) Apply for PAR 21 184 Funding Number: PAR 21 184 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional) Apply for PAR 21 175 Funding Number: PAR 21 175 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional) Apply for PAR 21 176 Funding Number: PAR 21 176 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Core Centers for Clinical Research (CCCR) (P30)- Clinical Trial Not Allowed Apply for RFA AR 22 002 Funding Number: RFA AR 22 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed) Apply for RFA AG 22 010 Funding Number: RFA AG 22 010 Agency: National Institutes of Health Category: Health Funding Amount: $139,000 |
| Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed) Apply for RFA AG 22 009 Funding Number: RFA AG 22 009 Agency: National Institutes of Health Category: Health Funding Amount: $139,000 |
| Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed) Apply for PAR 21 212 Funding Number: PAR 21 212 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional) Apply for RFA AT 21 006 Funding Number: RFA AT 21 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00) Apply for PAR 21 143 Funding Number: PAR 21 143 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed) Apply for RFA RM 21 022 Funding Number: RFA RM 21 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed) Apply for RFA RM 21 021 Funding Number: RFA RM 21 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed) Apply for RFA HG 21 007 Funding Number: RFA HG 21 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) Apply for RFA AI 21 009 Funding Number: RFA AI 21 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed) Apply for RFA HG 21 006 Funding Number: RFA HG 21 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44) Apply for RFA HG 21 008 Funding Number: RFA HG 21 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 21 012 Funding Number: RFA AI 21 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed) Apply for PAR 21 187 Funding Number: PAR 21 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed) Apply for RFA AR 21 016 Funding Number: RFA AR 21 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional) Apply for RFA AR 21 015 Funding Number: RFA AR 21 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) Apply for PAR 21 210 Funding Number: PAR 21 210 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 22 013", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
